Aimed Bio Inc. (0009K0.KQ)
KOSDAQ · KRW · Healthcare · Biotechnology
₩20,550 (-5.73%) as of
Key statistics
- Market cap
- 1.32T
- Dividend yield
- 0.00%
- 52-week range
- 17,400.00 – 80,200.00
- Revenue (TTM)
- 66.79B
- Profit margin
- 57.79%
- Volume
- 222.36k
About Aimed Bio Inc.
Aimed Bio Inc. develops therapeutic solutions for patients with brain diseases, including neuro-oncological and degenerative diseases. Its multidisciplinary platform offers antibody-drug conjugates, blood-brain barrier penetration, brain immune modulation, and patient-derived models (PDC/PDX). Aimed Bio Inc. was founded in 2018 and is based in Seoul, South Korea.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Seoul, South Korea
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.